Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons

Abstract Calcium ion (Ca2+) homeostasis is crucial for neuron function and neurotransmission. This study focused on the actions mediated by the CB1 receptor (CB1R), the most abundant G protein-coupled receptor (GPCR) in central nervous system (CNS) neurons, over by the AT1R, which is one of the few...

Full description

Saved in:
Bibliographic Details
Main Authors: Rafael Rivas-Santisteban, Ana Muñoz, Jaume Lillo, Iu Raïch, Ana I. Rodríguez-Pérez, Gemma Navarro, José L. Labandeira-García, Rafael Franco
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-024-00827-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846165379141861376
author Rafael Rivas-Santisteban
Ana Muñoz
Jaume Lillo
Iu Raïch
Ana I. Rodríguez-Pérez
Gemma Navarro
José L. Labandeira-García
Rafael Franco
author_facet Rafael Rivas-Santisteban
Ana Muñoz
Jaume Lillo
Iu Raïch
Ana I. Rodríguez-Pérez
Gemma Navarro
José L. Labandeira-García
Rafael Franco
author_sort Rafael Rivas-Santisteban
collection DOAJ
description Abstract Calcium ion (Ca2+) homeostasis is crucial for neuron function and neurotransmission. This study focused on the actions mediated by the CB1 receptor (CB1R), the most abundant G protein-coupled receptor (GPCR) in central nervous system (CNS) neurons, over by the AT1R, which is one of the few G protein-coupled CNS receptors able to regulate cytoplasmic Ca2+ levels. A functional interaction suggesting a direct association between these receptors was detected. AT1-CB1 receptor heteromers (AT1CB1Hets) were identified in HEK-293T cells by bioluminescence resonance energy transfer (BRET2). Functional interactions within the AT1-CB1 complex and their potential relevance in Parkinson’s disease (PD) were assessed. In situ proximity ligation assays (PLA) identified AT1CB1Hets in neurons, in which an important finding was that Ca2+ level increase upon AT1R activation was reduced in the presence of cannabinoids acting on CB1Rs. AT1CB1Het expression was quantified in samples from the 6-hydroxydopamine (6-OHDA) hemilesioned rat model of PD in which a lower expression of AT1CB1Hets was observed in striatal neurons from lesioned animals (versus non-lesioned). AT1CB1Het expression changed depending on both the lesion and the consequences of levodopa administration, i.e., dyskinesias versus lack of involuntary movements. A partial recovery in AT1CB1Het expression was detected in lesioned animals that developed levodopa-induced dyskinesias. These findings support the existence of a compensatory mechanism mediated by AT1CB1Hets that modulates susceptibility to levodopa-induced dyskinesias in PD. Therefore, cannabinoids may be useful in reducing calcium dyshomeostasis in dyskinesia.
format Article
id doaj-art-13cd6a6a7aa44df2aecc5b45a642df9e
institution Kabale University
issn 2373-8057
language English
publishDate 2024-11-01
publisher Nature Portfolio
record_format Article
series npj Parkinson's Disease
spelling doaj-art-13cd6a6a7aa44df2aecc5b45a642df9e2024-11-17T12:16:18ZengNature Portfolionpj Parkinson's Disease2373-80572024-11-0110111410.1038/s41531-024-00827-7Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neuronsRafael Rivas-Santisteban0Ana Muñoz1Jaume Lillo2Iu Raïch3Ana I. Rodríguez-Pérez4Gemma Navarro5José L. Labandeira-García6Rafael Franco7Laboratory of Computational Medicine, Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Campus BellaterraNetwork Center for Biomedical Research in Neurodegenerative Diseases, CiberNed, Spanish National Health Institute Carlos iiiNetwork Center for Biomedical Research in Neurodegenerative Diseases, CiberNed, Spanish National Health Institute Carlos iiiNetwork Center for Biomedical Research in Neurodegenerative Diseases, CiberNed, Spanish National Health Institute Carlos iiiNetwork Center for Biomedical Research in Neurodegenerative Diseases, CiberNed, Spanish National Health Institute Carlos iiiNetwork Center for Biomedical Research in Neurodegenerative Diseases, CiberNed, Spanish National Health Institute Carlos iiiNetwork Center for Biomedical Research in Neurodegenerative Diseases, CiberNed, Spanish National Health Institute Carlos iiiNetwork Center for Biomedical Research in Neurodegenerative Diseases, CiberNed, Spanish National Health Institute Carlos iiiAbstract Calcium ion (Ca2+) homeostasis is crucial for neuron function and neurotransmission. This study focused on the actions mediated by the CB1 receptor (CB1R), the most abundant G protein-coupled receptor (GPCR) in central nervous system (CNS) neurons, over by the AT1R, which is one of the few G protein-coupled CNS receptors able to regulate cytoplasmic Ca2+ levels. A functional interaction suggesting a direct association between these receptors was detected. AT1-CB1 receptor heteromers (AT1CB1Hets) were identified in HEK-293T cells by bioluminescence resonance energy transfer (BRET2). Functional interactions within the AT1-CB1 complex and their potential relevance in Parkinson’s disease (PD) were assessed. In situ proximity ligation assays (PLA) identified AT1CB1Hets in neurons, in which an important finding was that Ca2+ level increase upon AT1R activation was reduced in the presence of cannabinoids acting on CB1Rs. AT1CB1Het expression was quantified in samples from the 6-hydroxydopamine (6-OHDA) hemilesioned rat model of PD in which a lower expression of AT1CB1Hets was observed in striatal neurons from lesioned animals (versus non-lesioned). AT1CB1Het expression changed depending on both the lesion and the consequences of levodopa administration, i.e., dyskinesias versus lack of involuntary movements. A partial recovery in AT1CB1Het expression was detected in lesioned animals that developed levodopa-induced dyskinesias. These findings support the existence of a compensatory mechanism mediated by AT1CB1Hets that modulates susceptibility to levodopa-induced dyskinesias in PD. Therefore, cannabinoids may be useful in reducing calcium dyshomeostasis in dyskinesia.https://doi.org/10.1038/s41531-024-00827-7
spellingShingle Rafael Rivas-Santisteban
Ana Muñoz
Jaume Lillo
Iu Raïch
Ana I. Rodríguez-Pérez
Gemma Navarro
José L. Labandeira-García
Rafael Franco
Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
npj Parkinson's Disease
title Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
title_full Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
title_fullStr Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
title_full_unstemmed Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
title_short Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
title_sort cannabinoid regulation of angiotensin ii induced calcium signaling in striatal neurons
url https://doi.org/10.1038/s41531-024-00827-7
work_keys_str_mv AT rafaelrivassantisteban cannabinoidregulationofangiotensiniiinducedcalciumsignalinginstriatalneurons
AT anamunoz cannabinoidregulationofangiotensiniiinducedcalciumsignalinginstriatalneurons
AT jaumelillo cannabinoidregulationofangiotensiniiinducedcalciumsignalinginstriatalneurons
AT iuraich cannabinoidregulationofangiotensiniiinducedcalciumsignalinginstriatalneurons
AT anairodriguezperez cannabinoidregulationofangiotensiniiinducedcalciumsignalinginstriatalneurons
AT gemmanavarro cannabinoidregulationofangiotensiniiinducedcalciumsignalinginstriatalneurons
AT josellabandeiragarcia cannabinoidregulationofangiotensiniiinducedcalciumsignalinginstriatalneurons
AT rafaelfranco cannabinoidregulationofangiotensiniiinducedcalciumsignalinginstriatalneurons